SERA logo

SERA Sera Prognostics, Inc.

NASDAQ Global Market · Medical - Devices · Healthcare

$1.81
-0.08 (-4.23%)

Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, th…

Market Cap: $70.23Mwww.sera.com

Price

No data yet.

Social Signal Score

50
5d
—
30d
50
3 mentions
—
60d
50
4 mentions
—
90d
50
4 mentions
—
news: 4

Analyst Ratings

5 analysts
Buyconsensus
Strong Buy 0Buy 4Hold 1Sell 0Strong Sell 0
Avg price target$6+231.5%
Low $6Median $6High $6
Current Consensus

Revenue

$42.0K+425.00%
$0.00$41.0K$82.0K$123.0K
Mar 2020Sep 2026

Analyst Estimates

FY2025
$-0.70
$-0.89–$-0.46
2 analysts
FY2026
$-0.67
$-0.84–$-0.44
2 analysts
FY2027
$-0.57
$-0.73–$-0.38
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Zhenya Lindgardt
Sector
Healthcare
Industry
Medical - Devices
Employees
72
Beta
1.14
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
-5.43
www.sera.com